Enhanced Aggrus expression in cancer-associated fibroblasts (CAF) has also been reported, and Aggrus expression in CAFs predicted poor prognosis of lung adenocarcinomas [13]. This evidence concerns the gene PDPN and lung adenocarcinoma.